Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

• New Treatment Options for Type 2 Diabetes: A Patient-Centered Approach


New Treatment Options for Type 2 Diabetes: A Patient-Centered Approach will briefly review the psychophysiology and diagnosis of Type 2 diabetes as well as review the most recently approved medication used for treating Type 2 diabetes; including glucagon-like peptide-1 receptors agonist, dieotidyl peptidases-4 inhibitors and sodium0glucose co-transporter in hibitors as well as the new insulin formations.This course is presented by: Betsy Carlise, Pharm D, CDE, Clinical Pharamcy Specialist, Seton Medical Center Hays. 
 
 

Fee

$15.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
 

Requirements for CE Credit

 
 

The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This online activity is approved for 0.1 CEUs (1.00 contact hours) of continuing education credit.  In order to receive 1.00 contact hours of CE credit, the participant must watch the video in their entirety, complete the online post-test, and complete the online evaluation. 

 

 

 

Objectives

  • Briefly review the pathophysiology and diagnosis of Type 2 diabetes
  • Differentiate between the risks and benefits of novel hypoglycemic agents.
  • Examine the role of these new agents in the therapeutic management of diabetes.

Speaker(s)/Author(s)

Betsy Carlisle, Pharm.D., CDE
Clinical Pharmacy Specilaist, Seaton Medical Center Hays

Activity Number

0067-0000-15-013-H01-P/T

Release Date: May 5, 2016
Credit Expiration Date: Apr 1, 2019

CE Hours

1.00